v3.20.2
Condensed Balance Sheets - USD ($)
Sep. 30, 2020
Dec. 31, 2019
Current Assets    
Cash $ 8,891,612 $ 25,063
Accounts receivable 12,584,296 2,075,380
Factor receivables, net 2,107,082 174,042
Inventory 6,684,030 2,215,497
Prepaid assets 1,045,210 254,070
Note receivable 1,480,000 4,480,000
Total Current Assets 32,792,230 9,224,052
Other Assets    
Property and equipment, net 2,352,561 1,029,885
Other assets 221,168 215,688
Total Assets 35,365,959 10,469,625
Current Liabilities    
Accounts payable 5,508,639 2,536,871
Accrued expenses 548,066 364,309
Factor loan payable 1,513,885 125,645
Convertible notes payable, net of discount 1,945,065 4,216,307
Total Current Liabilities 9,515,655 7,243,132
Total Liabilities 9,515,655 7,243,132
Commitment and Contingencies (Note 5)
Shareholders' Equity    
Common stock, $0.0001 par value, 200,000,000 shares authorized, 38,414,631 and 3,300,015 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively 3,842 330
Additional paid-in capital 75,412,814 41,823,048
Accumulated deficit (49,566,352) (43,413,370)
Total Shareholders' Equity 25,850,304 3,226,493
Total Liabilities and Shareholders' Equity 35,365,959 10,469,625
Series D Preferred Stock [Member]    
Shareholders' Equity    
Preferred Stock value  
Total Shareholders' Equity   4,816,485
Series D Preferred Stock [Member]    
Shareholders' Equity    
Preferred Stock value   $ 4,816,485

Source